Greater Cannabis Company (GCAN) Acquisitions (2020)

Greater Cannabis Company (GCAN) recorded quarterly Acquisitions of $25000.0 in Q1 2020.

Greater Cannabis Company (GCAN) Acquisitions (2020) Analysis & Trends

Greater Cannabis Company's Acquisitions history runs 1 years deep, the most recent figure standing at $25000.0 for Q1 2020.

  • In Q1 2020, Acquisitions changed N/A year-over-year to $25000.0; the TTM figure through Dec 2020 stood at $25000.0 (changed N/A YoY), while the FY2020 annual figure was $25000.0, changed N/A from the prior year.
  • Acquisitions was $25000.0 for Q1 2020 at Greater Cannabis Company.
  • In the past five years, Acquisitions ranged from a high of $25000.0 in Q1 2020 to a low of $25000.0 in Q1 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn -
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn -
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn -
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn -
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn -
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 2.09 Bn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn -
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 137.87 Mn
10 Greater Cannabis Company - - - -

Historic Data

Download Data
DateValue
Mar 31, 2020 25,000.00